Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
European Urology Oncology
|
October 17, 2025
Endoscopic Thulium Laser Ablation with Disitamab Vedotin and Immunotherapy in High-risk Upper Tract Urothelial Carcinoma: A Prospective Pilot Study of a Novel Kidney-sparing Strategy
Jianjun Ye, Zeyu Chen, Xinyang Liao, et al.
Urologic Oncology
|
August 10, 2023
Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy
Jiwei Huang, Ruopeng Su, Cuijian Zhang, et al.
Cancer Medicine
|
March 23, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study
Ruopeng Su, Zeyu Chen, Daoping Hong, et al.
Chinese Medical Journal
|
June 30, 2023
Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer
Shi Qiu, Yaqi Qiu, Linghui Deng, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2025
MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment
Inbar A Habaz, Xuejin Ou, Nicole I Wang, et al.
Cancer Medicine
|
September 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study
Ruopeng Su, Tingxuan Huang, Liangyou Gu, et al.
Current Opinion in Urology
|
October 9, 2025
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels
Benjamin Pradere, Maarten Schuit, Félix Guerrero-Ramos, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study
Cheoklong Ng, Taile Jing, Shicheng Yu, et al.
Clinical Genitourinary Cancer
|
May 10, 2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma
Cheoklong Ng, Cheng Peng, Shangqian Wang, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
European Urology Oncology
|
October 17, 2025
Endoscopic Thulium Laser Ablation with Disitamab Vedotin and Immunotherapy in High-risk Upper Tract Urothelial Carcinoma: A Prospective Pilot Study of a Novel Kidney-sparing Strategy
Jianjun Ye, Zeyu Chen, Xinyang Liao, et al.
Urologic Oncology
|
August 10, 2023
Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy
Jiwei Huang, Ruopeng Su, Cuijian Zhang, et al.
Cancer Medicine
|
March 23, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study
Ruopeng Su, Zeyu Chen, Daoping Hong, et al.
Chinese Medical Journal
|
June 30, 2023
Cell softness reveals tumorigenic potential via ITGB8/AKT/glycolysis signaling in a mice model of orthotopic bladder cancer
Shi Qiu, Yaqi Qiu, Linghui Deng, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2025
MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment
Inbar A Habaz, Xuejin Ou, Nicole I Wang, et al.
Cancer Medicine
|
September 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study
Ruopeng Su, Tingxuan Huang, Liangyou Gu, et al.
Current Opinion in Urology
|
October 9, 2025
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels
Benjamin Pradere, Maarten Schuit, Félix Guerrero-Ramos, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study
Cheoklong Ng, Taile Jing, Shicheng Yu, et al.
Clinical Genitourinary Cancer
|
May 10, 2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma
Cheoklong Ng, Cheng Peng, Shangqian Wang, et al.
Page
of 8